{
    "nct_id": "NCT01078168",
    "title": "Changes of Cerebral Spinal Fluid APPS\u03b1 Levels Under Oral Therapy With Acitretin 30 mg Daily in Patients With Mild to Moderate Alzheimer's Disease: a Multicenter Prospective Randomised Placebo-controlled Parallel-group Study",
    "status": "COMPLETED",
    "last_update_time": "2017-07-18",
    "description_brief": "The trials investigates the changes of cerebral spinal fluid (CSF) soluble alpha-secretase cleaved APP (APPs\u03b1) levels under oral therapy with acitretin 30mg daily in patients with mild to moderate Alzheimer's disease (AD).The present study aims to demonstrate an enhancement of the \u03b1-secretase activity by acitretin as measured by increased CSF APPS\u03b1 levels in human AD. Second, the safety and tolerability of acitretin in AD patients should be proven.",
    "description_detailed": "N/A",
    "phase": [
        "PHASE2"
    ],
    "study_type": "INTERVENTIONAL",
    "primary_purpose": "TREATMENT",
    "results": {
        "participantFlowModule": {
            "preAssignmentDetails": "neuropsychiatric testing, general exclusion of e.g. depression or severe diseases affecting the trial",
            "recruitmentDetails": "University Medical Centre of the Johannes Gutenberg University, Mainz, and University Medical Centre, Rostock, May 2010 to January 2013",
            "groups": [
                {
                    "id": "FG000",
                    "title": "Acitretin",
                    "description": "oral, 30 mg per day, day 1-28\n\nAcitretin: 30mg per day from Day 1 to Day 28"
                },
                {
                    "id": "FG001",
                    "title": "Placebo",
                    "description": "oral, day 1-28\n\nPlacebo: Placebo"
                }
            ],
            "periods": [
                {
                    "title": "Overall Study",
                    "milestones": [
                        {
                            "type": "STARTED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "11"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "11"
                                }
                            ]
                        },
                        {
                            "type": "COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "11"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "10"
                                }
                            ]
                        },
                        {
                            "type": "NOT COMPLETED",
                            "achievements": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "1"
                                }
                            ]
                        }
                    ],
                    "dropWithdraws": [
                        {
                            "type": "Physician Decision",
                            "reasons": [
                                {
                                    "groupId": "FG000",
                                    "numSubjects": "0"
                                },
                                {
                                    "groupId": "FG001",
                                    "numSubjects": "1"
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "baselineCharacteristicsModule": {
            "groups": [
                {
                    "id": "BG000",
                    "title": "Acitretin",
                    "description": "oral, 30 mg per day, day 1-28\n\nAcitretin: 30mg per day from Day 1 to Day 28"
                },
                {
                    "id": "BG001",
                    "title": "Placebo",
                    "description": "oral, day 1-28\n\nPlacebo: Placebo"
                },
                {
                    "id": "BG002",
                    "title": "Total",
                    "description": "Total of all reporting groups"
                }
            ],
            "denoms": [
                {
                    "units": "Participants",
                    "counts": [
                        {
                            "groupId": "BG000",
                            "value": "11"
                        },
                        {
                            "groupId": "BG001",
                            "value": "10"
                        },
                        {
                            "groupId": "BG002",
                            "value": "21"
                        }
                    ]
                }
            ],
            "measures": [
                {
                    "title": "Age, Continuous",
                    "paramType": "MEAN",
                    "dispersionType": "STANDARD_DEVIATION",
                    "unitOfMeasure": "years",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "66.9",
                                            "spread": "9.6"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "73",
                                            "spread": "3.8"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "69.33",
                                            "spread": "7.9"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Sex: Female, Male",
                    "paramType": "COUNT_OF_PARTICIPANTS",
                    "unitOfMeasure": "Participants",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "title": "Female",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "9"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "6"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "15"
                                        }
                                    ]
                                },
                                {
                                    "title": "Male",
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "2"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "4"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "6"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "Region of Enrollment",
                    "paramType": "NUMBER",
                    "unitOfMeasure": "participants",
                    "classes": [
                        {
                            "title": "Germany",
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "11"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "10"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "21"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                },
                {
                    "title": "MMSE",
                    "description": "MMSE: Mini-Mental State Examination; can be used to systematically and thoroughly assess mental status; range: 0-30; a score of 23 or lower is indicative of cognitive impairment",
                    "paramType": "MEAN",
                    "dispersionType": "STANDARD_DEVIATION",
                    "unitOfMeasure": "units on a scale",
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "BG000",
                                            "value": "20.4",
                                            "spread": "4.2"
                                        },
                                        {
                                            "groupId": "BG001",
                                            "value": "23.9",
                                            "spread": "4.3"
                                        },
                                        {
                                            "groupId": "BG002",
                                            "value": "22.2",
                                            "spread": "4.5"
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        "outcomeMeasuresModule": {
            "outcomeMeasures": [
                {
                    "type": "PRIMARY",
                    "title": "Difference in Cerebrospinal Fluid (CSF) Soluble Alpha-clevaed Amyloid Precursor Protein (APPs\u03b1) Concentration at Visit 3 Compared to Baseline",
                    "description": "Values were assessed via Western blotting technique. Normalization was conducted using hSA levels of the individual samples.",
                    "populationDescription": "All patients were included with successful punctation at V1 and V3. For one Acitretin-treated patient not punctation at V3 was obtained (resulting n of 10).",
                    "reportingStatus": "POSTED",
                    "paramType": "MEAN",
                    "dispersionType": "Standard Deviation",
                    "unitOfMeasure": "fold change (Visit 3/background)",
                    "timeFrame": "baseline and 4 weeks (visit 3)",
                    "groups": [
                        {
                            "id": "OG000",
                            "title": "Acitretin",
                            "description": "oral, 30 mg per day, day 1-28\n\nAcitretin: 30mg per day from Day 1 to Day 28"
                        },
                        {
                            "id": "OG001",
                            "title": "Placebo",
                            "description": "oral, day 1-28\n\nPlacebo: Placebo"
                        }
                    ],
                    "denoms": [
                        {
                            "units": "Participants",
                            "counts": [
                                {
                                    "groupId": "OG000",
                                    "value": "10"
                                },
                                {
                                    "groupId": "OG001",
                                    "value": "10"
                                }
                            ]
                        }
                    ],
                    "classes": [
                        {
                            "categories": [
                                {
                                    "measurements": [
                                        {
                                            "groupId": "OG000",
                                            "value": "1.251",
                                            "spread": "0.4528"
                                        },
                                        {
                                            "groupId": "OG001",
                                            "value": "0.8741",
                                            "spread": "0.2592"
                                        }
                                    ]
                                }
                            ]
                        }
                    ],
                    "analyses": [
                        {
                            "groupIds": [
                                "OG000",
                                "OG001"
                            ],
                            "nonInferiorityType": "SUPERIORITY_OR_OTHER",
                            "pValue": "0.0347",
                            "pValueComment": "threshold: p\\<0.05",
                            "statisticalMethod": "t-test, 2 sided",
                            "paramType": "Mean Difference (Final Values)",
                            "paramValue": "0.3769",
                            "ciPctValue": "95",
                            "ciNumSides": "TWO_SIDED",
                            "ciLowerLimit": "0.03025",
                            "ciUpperLimit": "0.7235"
                        }
                    ]
                }
            ]
        },
        "adverseEventsModule": {
            "frequencyThreshold": "0",
            "eventGroups": [
                {
                    "id": "EG000",
                    "title": "Acitretin",
                    "description": "oral, 30 mg per day, day 1-28\n\nAcitretin: 30mg per day from Day 1 to Day 28",
                    "seriousNumAffected": 1,
                    "seriousNumAtRisk": 11,
                    "otherNumAffected": 8,
                    "otherNumAtRisk": 11
                },
                {
                    "id": "EG001",
                    "title": "Placebo",
                    "description": "oral, day 1-28\n\nPlacebo: Placebo",
                    "seriousNumAffected": 0,
                    "seriousNumAtRisk": 10,
                    "otherNumAffected": 5,
                    "otherNumAtRisk": 10
                }
            ],
            "seriousEvents": [
                {
                    "term": "persistent diarrhea",
                    "organSystem": "Gastrointestinal disorders",
                    "notes": "diagnostic workup because of persistent diarrhea required hospitalization",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 10
                        }
                    ]
                }
            ],
            "otherEvents": [
                {
                    "term": "headache",
                    "organSystem": "General disorders",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 10
                        }
                    ]
                },
                {
                    "term": "migraine",
                    "organSystem": "General disorders",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 10
                        }
                    ]
                },
                {
                    "term": "syncope",
                    "organSystem": "General disorders",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 10
                        }
                    ]
                },
                {
                    "term": "light headedness",
                    "organSystem": "General disorders",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 10
                        }
                    ]
                },
                {
                    "term": "derailment of blood glucose",
                    "organSystem": "General disorders",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 10
                        }
                    ]
                },
                {
                    "term": "lowered glucose tolerance",
                    "organSystem": "General disorders",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 10
                        }
                    ]
                },
                {
                    "term": "aggressiveness",
                    "organSystem": "General disorders",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 10
                        }
                    ]
                },
                {
                    "term": "muscular pain",
                    "organSystem": "Musculoskeletal and connective tissue disorders",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 10
                        }
                    ]
                },
                {
                    "term": "cataract surgery",
                    "organSystem": "Surgical and medical procedures",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 10
                        }
                    ]
                },
                {
                    "term": "memory defect due to anaesthesia",
                    "organSystem": "Surgical and medical procedures",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 10
                        }
                    ]
                },
                {
                    "term": "gastroenteritis",
                    "organSystem": "Gastrointestinal disorders",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 10
                        }
                    ]
                },
                {
                    "term": "diarrhea",
                    "organSystem": "Gastrointestinal disorders",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 10
                        }
                    ]
                },
                {
                    "term": "severe diarrhea",
                    "organSystem": "Gastrointestinal disorders",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 10
                        }
                    ]
                },
                {
                    "term": "post-punctual syndrome",
                    "organSystem": "Surgical and medical procedures",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 10
                        }
                    ]
                },
                {
                    "term": "exfoliation of callus",
                    "organSystem": "Skin and subcutaneous tissue disorders",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 4,
                            "numAffected": 4,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 10
                        }
                    ]
                },
                {
                    "term": "dry lips",
                    "organSystem": "Skin and subcutaneous tissue disorders",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 5,
                            "numAffected": 5,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 10
                        }
                    ]
                },
                {
                    "term": "dry eyes",
                    "organSystem": "Skin and subcutaneous tissue disorders",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 10
                        }
                    ]
                },
                {
                    "term": "alopecia",
                    "organSystem": "Skin and subcutaneous tissue disorders",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 10
                        }
                    ]
                },
                {
                    "term": "hypertensive crisis",
                    "organSystem": "Blood and lymphatic system disorders",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 4,
                            "numAffected": 2,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 10
                        }
                    ]
                },
                {
                    "term": "gingivitis",
                    "organSystem": "Skin and subcutaneous tissue disorders",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 10
                        }
                    ]
                },
                {
                    "term": "pruritus",
                    "organSystem": "Skin and subcutaneous tissue disorders",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 2,
                            "numAffected": 2,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 10
                        }
                    ]
                },
                {
                    "term": "eczema",
                    "organSystem": "Skin and subcutaneous tissue disorders",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 10
                        }
                    ]
                },
                {
                    "term": "dry skin",
                    "organSystem": "Skin and subcutaneous tissue disorders",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 10
                        }
                    ]
                },
                {
                    "term": "backpain",
                    "organSystem": "General disorders",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 10
                        }
                    ]
                },
                {
                    "term": "dry mouth",
                    "organSystem": "Skin and subcutaneous tissue disorders",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 10
                        }
                    ]
                },
                {
                    "term": "infection due to insect sting",
                    "organSystem": "Skin and subcutaneous tissue disorders",
                    "stats": [
                        {
                            "groupId": "EG000",
                            "numEvents": 1,
                            "numAffected": 1,
                            "numAtRisk": 11
                        },
                        {
                            "groupId": "EG001",
                            "numEvents": 0,
                            "numAffected": 0,
                            "numAtRisk": 10
                        }
                    ]
                }
            ]
        },
        "moreInfoModule": {
            "certainAgreement": {
                "piSponsorEmployee": true
            },
            "pointOfContact": {
                "title": "Prof. Dr. Andreas Fellgiebel",
                "organization": "Clinic of Psychiatry and Psychotherapy, University Medical Center JGU Mainz",
                "email": "Andreas.Fellgiebel@unimedizin-mainz.de",
                "phone": "+49-6131-17-7363"
            }
        }
    },
    "target_category": "disease-targeted small molecule",
    "drug": [
        "Acitretin (oral, 30 mg daily)"
    ],
    "placebo": [
        "Placebo"
    ],
    "explanation_target": [
        "Reason: The trial tests acitretin to increase \u03b1\u2011secretase activity (measured as CSF APPs\u03b1) to shift APP processing to the non-amyloidogenic pathway \u2014 i.e., a mechanism-directed attempt to modify Alzheimer pathology rather than a symptomatic cognitive enhancer or behavioral treatment. \ue200cite\ue202turn0search0\ue202turn0search6\ue201",
        "Act (key extracted details and supporting sources): acitretin is an oral systemic retinoid/small molecule (brand Soriatane) used in dermatology and known to act via retinoic acid/retinoid receptors. The published pilot/randomized placebo\u2011controlled studies measured CSF APPs\u03b1 increases after acitretin 30 mg/day and reported a significant rise in CSF APPs\u03b1 vs placebo; the trial title/registry matches the study design described. \ue200cite\ue202turn0search6\ue202turn0search0\ue202turn0search4\ue202turn0search1\ue201",
        "Reflect: Classification as a 'disease-targeted small molecule' is appropriate because acitretin is a small\u2011molecule retinoid that modulates APP processing (upregulates \u03b1\u2011secretase/ADAM10 activity) \u2014 a disease\u2011pathology directed mechanism. Safety/tolerability were secondary endpoints in the cited study, consistent with a repurposing/targeted\u2011mechanism small\u2011molecule trial rather than a purely symptomatic or diagnostic study. No major ambiguity in category assignment. \ue200cite\ue202turn0search0\ue202turn0search6\ue201"
    ],
    "agent_type": "A) Amyloid beta",
    "explanation_agent": [
        "Reason: The intervention (acitretin, an oral retinoid) is used to upregulate \u03b1\u2011secretase (ADAM10) activity and thereby increase production of the non\u2011amyloidogenic APP fragment APPs\u03b1\u2014i.e., it aims to shift APP processing away from \u03b2/\u03b3 cleavage and reduce amyloidogenic A\u03b2 generation. \ue200cite\ue202turn0search4\ue202turn0search0\ue201",
        "Act: Key extracted details \u2014 acitretin (Soriatane) is a small\u2011molecule systemic retinoid; a randomized, placebo\u2011controlled 4\u2011week study of acitretin 30 mg/day in mild\u2013moderate AD showed a significant increase in CSF APPs\u03b1 versus placebo (primary endpoint), consistent with induction of ADAM10/\u03b1\u2011secretase. Trial registry and publications report the 30 mg/day oral dosing and CSF APPs\u03b1 outcome. \ue200cite\ue202turn0search1\ue202turn0search0\ue202turn0search7\ue201",
        "Reflect: This mechanism directly modulates APP processing to reduce amyloid production rather than targeting downstream tau, inflammation, synaptic receptors, or symptomatic neurotransmission. That places the trial squarely in CADRO category A) Amyloid beta (disease\u2011directed anti\u2011amyloid strategy via enhancing non\u2011amyloidogenic cleavage). The cited human pilot RCT and preclinical studies support this attribution. \ue200cite\ue202turn0search0\ue202turn0search4\ue201",
        "Web search results (supporting sources): Neurology (2014) pilot RCT \u2014 increased CSF APPs\u2011\u03b1 with acitretin (30 mg/day). \ue200cite\ue202turn0search0\ue201; PubMed entry for the Neurology paper. \ue200cite\ue202turn0search2\ue201; FASEB J preclinical study showing retinoid/acitretin up\u2011regulates ADAM10 and non\u2011amyloidogenic APP processing. \ue200cite\ue202turn0search4\ue201; ALZFORUM summary of acitretin trial(s). \ue200cite\ue202turn0search1\ue201; trial registry/record showing design and outcomes for the 30 mg/day, 4\u2011week study. \ue200cite\ue202turn0search7\ue201"
    ]
}